dc.creator | Morales-Camilo N. | |
dc.creator | Salas C.O. | |
dc.creator | Sanhueza C. | |
dc.creator | Espinosa-Bustos C. | |
dc.creator | Sepúlveda-Boza S. | |
dc.creator | Reyes-Parada M. | |
dc.creator | Gonzalez-Nilo F. | |
dc.creator | Caroli-Rezende M. | |
dc.creator | Fierro A. | |
dc.date.accessioned | 2020-09-02T22:23:38Z | |
dc.date.accessioned | 2022-11-08T20:28:27Z | |
dc.date.available | 2020-09-02T22:23:38Z | |
dc.date.available | 2022-11-08T20:28:27Z | |
dc.date.created | 2020-09-02T22:23:38Z | |
dc.date.issued | 2015 | |
dc.identifier | 85, 6, 685-695 | |
dc.identifier | 17470277 | |
dc.identifier | https://hdl.handle.net/20.500.12728/5432 | |
dc.identifier.uri | https://repositorioslatinoamericanos.uchile.cl/handle/2250/5146828 | |
dc.language | en | |
dc.publisher | Blackwell Publishing Ltd | |
dc.subject | aurones | |
dc.subject | chalcones | |
dc.subject | molecular modeling | |
dc.subject | monoamine oxidase inhibitors | |
dc.subject | QSAR | |
dc.subject | 1 (2 hydroxy 5 methoxyphenyl) 3 (2,4,5 trimethoxyphenyl)prop 2 en 1 one | |
dc.subject | 1 (2 hydroxy 6 methoxyphenyl) 3 (2,4,5 trimethoxyphenyl)prop 2 en 1 one | |
dc.subject | 2 (2,3 dimethoxybenzylidene) 4 methoxybenzofuran 3(2h) one | |
dc.subject | 2 (2,3 dimethoxybenzylidene) 5 methoxybenzofuran 3(2h) one | |
dc.subject | 2 (2,4,5 trimethoxybenzylidene) 4 methoxybenzofuran 3(2h) one | |
dc.subject | 2 (2,4,5 trimethoxybenzylidene) 5 methoxybenzofuran 3(2h) one | |
dc.subject | 2 (2,5 dimethoxybenzylidene) 4 methoxybenzofuran 3(2h) one | |
dc.subject | 2 (2,5 dimethoxybenzylidene) 5 methoxybenzofuran 3(2h) one | |
dc.subject | 2 (4 bromo 2,5 dimethoxybenzylidene) 4 methoxybenzofuran 3(2h) one | |
dc.subject | 2 (4 bromo 2,5 dimethoxybenzylidene) 5 methoxybenzofuran 3(2h) one | |
dc.subject | 3 (2,3 dimethoxyphenyl) 1 (2 hydroxy 5 methoxyphenyl)prop 2 en 1 one | |
dc.subject | 3 (2,3 dimethoxyphenyl) 1 (2 hydroxy 6 methoxyphenyl)prop 2 en 1 one | |
dc.subject | 3 (2,5 dimethoxyphenyl) 1 (2 hydroxy 5 methoxyphenyl)prop 2 en 1 one | |
dc.subject | 3 (2,5 dimethoxyphenyl) 1 (2 hydroxy 6 methoxyphenyl)prop 2 en 1 one | |
dc.subject | 3 (4 bromo 2,5 dimethoxyphenyl) 1 (2 hydroxy 5 methoxyphenyl)prop 2 en 1 one | |
dc.subject | 3 (4 bromo 2,5 dimethoxyphenyl) 1 (2 hydroxy 6 methoxyphenyl)prop 2 en 1 one | |
dc.subject | amine oxidase (flavin containing) isoenzyme B | |
dc.subject | aurone derivative | |
dc.subject | chalcone derivative | |
dc.subject | monoamine oxidase B inhibitor | |
dc.subject | natural products and their synthetic derivatives | |
dc.subject | unclassified drug | |
dc.subject | amine oxidase (flavin containing) | |
dc.subject | aurone | |
dc.subject | benzofuran derivative | |
dc.subject | chalcone derivative | |
dc.subject | monoamine oxidase inhibitor | |
dc.subject | Article | |
dc.subject | biological activity | |
dc.subject | drug design | |
dc.subject | drug screening | |
dc.subject | drug synthesis | |
dc.subject | enzyme inhibition | |
dc.subject | human | |
dc.subject | IC50 | |
dc.subject | in vitro study | |
dc.subject | molecular docking | |
dc.subject | molecular dynamics | |
dc.subject | molecular mechanics | |
dc.subject | molecular model | |
dc.subject | nonhuman | |
dc.subject | priority journal | |
dc.subject | quantitative structure activity relation | |
dc.subject | rat | |
dc.subject | chemistry | |
dc.subject | metabolism | |
dc.subject | synthesis | |
dc.subject | Benzofurans | |
dc.subject | Chalcones | |
dc.subject | Humans | |
dc.subject | Molecular Docking Simulation | |
dc.subject | Monoamine Oxidase | |
dc.subject | Monoamine Oxidase Inhibitors | |
dc.subject | Quantitative Structure-Activity Relationship | |
dc.title | Synthesis, biological evaluation, and molecular simulation of chalcones and aurones as selective MAO-B inhibitors | |
dc.type | Article | |